Human UBE2D3, recombinant

Human UBE2D3, recombinant
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NOV-CH10.10ug 10 µg - -

Fragen Sie uns nach der Lieferzeit

30,00 €
NOV-CH10.50ug 50 µg - -

Fragen Sie uns nach der Lieferzeit

90,00 €
NOV-CH10.500ug 500 µg - -

Fragen Sie uns nach der Lieferzeit

600,00 €
NOV-CH10.1mg 1 mg - -

Fragen Sie uns nach der Lieferzeit

950,00 €
 
Recombinant Human Ubiquitin-conjugating Enzyme E2 D3 is produced by our E.coli expression system... mehr
Produktinformationen "Human UBE2D3, recombinant"
Recombinant Human Ubiquitin-conjugating Enzyme E2 D3 is produced by our E.coli expression system and the target gene encoding Met1-Met147 is expressed. Protein function: Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. Acts also as an initiator E2, in conjunction with RNF8, for the priming of PCNA. Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair. Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus. In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53. Supports NRDP1-mediated ubiquitination and degradation of ERBB3 and of BRUCE which triggers apoptosis. In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes. In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction. Together with RNF135, catalyzes the viral RNA-dependent 'Lys-63'-linked polyubiquitination of RIG-I/DDX58 to activate the downstream signaling pathway that leads to interferon beta production (PubMed:28469175). [The UniProt Consortium]
Schlagworte: UBC5C, UBE2D3, Ubiquitin-protein ligase D3, Ubiquitin carrier protein D3, E2 ubiquitin-conjugating enzyme D3, Ubiquitin-conjugating enzyme E2 D3, Ubiquitin-conjugating enzyme E2(17)KB 3, Ubiquitin-conjugating enzyme E2-17 kDa 3, Recombinant Human UBE2D3
Hersteller: Novoprotein
Hersteller-Nr: CH10

Eigenschaften

Konjugat: No
Wirt: E.coli
Spezies-Reaktivität: human
MW: 16.6 kD
Format: Solution

Datenbank Information

KEGG ID : K06689 | Passende Produkte
UniProt ID : P61077 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -80°C (avoid repeat freezing and thawing cycles)
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Human UBE2D3, recombinant"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen